Steven Pavletic is a Hematopoietic Stem Cell Transplantation physician affiliated with National Institutes of Health. OpenAlex indexes 588 publications with 32,531 citations (h-index 71); ClinicalTrials.gov lists 8 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory.
Data verified 17 Aug 2026
Overview
Updated 27 Aug 2026
Steven Pavletic, MD, is affiliated with National Institutes of Health. The public record shows 588 publications with 32,531 citations (h-index 71), centered on Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia research, T-cell and B-cell Immunology. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 2 companies.
- Most recent indexed publication: 2026 · Bone marrow transplantation
- Top research focus: Hematopoietic Stem Cell Transplantation
- 8 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 10 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 242.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
- Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
Sponsor: National Cancer Institute (NCI)
- Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
Sponsor: National Cancer Institute (NCI)
- Collection of Saliva and/ or Peripheral Blood From Healthy Volunteers for Research
Sponsor: National Cancer Institute (NCI)
Industry payments
Updated 27 Aug 2026
2 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20255 payments$11,077openpaymentsdata.cms.gov ↗
- SANOFI-AVENTIS U.S. LLCProgram year20242 payments
- SANOFI-AVENTIS U.S. LLCProgram year20231 payment
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 27 Aug 2026
27 congress contributions (2004–2025) across AACR, ASCO, ASH per OpenAlex. The most recent:
- Lymphotoxin alpha (LTA) secretion correlates with gene expression and myeloid malignancy disease state
ASH Annual Meeting
ASH2025Co-author - T cell receptors targeting mutant NPM1 for adoptive cell therapy in acute myeloid leukemia
ASH Annual Meeting
ASH2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Von Willebrand factor and factor VIII as potential biomarkers for diagnosis and disease monitoring in chronic graft-versus-host disease.
Bone marrow transplantation
Clinical Trial2026 - Belumosudil reduces oral chronic graft-versus-host disease tissue inflammation and fibrosis: a ROCKstar companion study.
Blood advances
Clinical Trial2025 - Prevalence of clonal hematopoiesis of indeterminate potential in patients with severe chronic graft-versus-host disease.
Bone marrow transplantation
Letter2025
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03
- 04
- 05Risk factors for acute GVHD and survival after hematopoietic cell transplantationArticle705 citations2011
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- ResearchGate
researchgate.net/scientific-contributions/Steven-Z-Pavletic-39518377
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - Doximity
doximity.com/pub/steven-pavletic-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/steven-pavletic
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Other
ccr.cancer.gov/staff-directory/steven-z-pavletic
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ccr.cancer.gov ↗ - Other
astct.org/Nucleus/Article/the-role-of-lifestyle-medicine-in-chronic-gvhd-with-dr-steven-pavletic
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →astct.org ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Edward Lakatta, MD
National Institutes of Health
Douglas Lowy, MD
National Institutes of Health
Jerome Fleg, MD
National Institutes of Health
Robert Star, MD
National Institutes of Health